Browse all 9 CVE security advisories affecting Becton, Dickinson and Company (BD). AI-powered Chinese analysis, POCs, and references for each vulnerability.
Becton, Dickinson and Company (BD) develops medical technologies and laboratory equipment, with core use cases in healthcare diagnostics and drug delivery. Historically, common vulnerabilities include remote code execution, cross-site scripting, and privilege escalation, often affecting web interfaces and connected devices. The company maintains a moderate security posture with 9 CVEs on record, though no major public incidents have been widely reported. BD's products, while critical to healthcare, face typical IoT and web application security challenges, requiring ongoing vulnerability management to protect sensitive patient data and maintain operational integrity in clinical environments.
| CVE ID | Title | CVSS | Severity | Published |
|---|---|---|---|---|
| CVE-2023-29066 | Incorrect User Management — FACSChorus CWE-266 | 3.2 | Low | 2023-11-28 |
| CVE-2023-29065 | Overly Permissive Access Policy — FACSChorus CWE-277 | 4.1 | Medium | 2023-11-28 |
| CVE-2023-29064 | Hardcoded Secrets — FACSChorus CWE-798 | 4.1 | Medium | 2023-11-28 |
| CVE-2023-29063 | Lack of DMA Access Protections — FACSChorus CWE-1299 | 2.4 | Low | 2023-11-28 |
| CVE-2023-29062 | Unsecure Identity Verification — FACSChorus CWE-287 | 3.8 | Low | 2023-11-28 |
| CVE-2023-29061 | Lack of Adequate BIOS Authentication — FACSChorus CWE-306 | 5.2 | Medium | 2023-11-28 |
| CVE-2023-29060 | Lack of USB Whitelisting — FACSChorus CWE-1299 | 5.4 | Medium | 2023-11-28 |
This page lists every published CVE security advisory associated with Becton, Dickinson and Company (BD). Each entry links to a detailed page with CVSS scoring, CWE classification, affected products and references. AI-generated Chinese analysis is provided for fast triage.